| Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide Z Wei, O Bai, JS Richardson, DD Mousseau, XM Li Journal of neuroscience research 73 (3), 364-368, 2003 | 189 | 2003 |
| Current theories on the pathogenesis of hepatic encephalopathy DD Mousseau, RF Butterworth Proceedings of the Society for Experimental Biology and Medicine 206 (4 …, 1994 | 134 | 1994 |
| The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta‐analysis J Moraros, C Nwankwo, SB Patten, DD Mousseau Depression and anxiety 34 (3), 217-226, 2017 | 121 | 2017 |
| Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy DD Mousseau, P Perney, GP Layrargues, RF Butterworth Neuroscience letters 162 (1-2), 192-196, 1993 | 114 | 1993 |
| An update on amine oxidase inhibitors: multifaceted drugs MS Song, D Matveychuk, EM MacKenzie, M Duchcherer, DD Mousseau, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 44, 118-124, 2013 | 104 | 2013 |
| PILRα, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRβ DD Mousseau, D Banville, D L'Abbé, P Bouchard, SH Shen Journal of Biological Chemistry 275 (6), 4467-4474, 2000 | 103 | 2000 |
| Atypical antipsychotics attenuate neurotoxicity of β‐amyloid (25–35) by modulating Bax and Bcl‐Xl/s expression and localization Z Wei, DD Mousseau, JS Richardson, LE Dyck, XM Li Journal of neuroscience research 74 (6), 942-947, 2003 | 92 | 2003 |
| Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy DD Mousseau, GB Baker, RF Butterworth Journal of neurochemistry 68 (3), 1200-1208, 1997 | 75 | 1997 |
| Lacunar-canalicular network in femoral cortical bone is reduced in aged women and is predominantly due to a loss of canalicular porosity AM Ashique, LS Hart, CDL Thomas, JG Clement, P Pivonka, Y Carter, ... Bone reports 7, 9-16, 2017 | 72* | 2017 |
| Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS Z Wei, DD Mousseau, Y Dai, X Cao, XM Li The pharmacogenomics journal 6 (4), 279-288, 2006 | 63 | 2006 |
| Dosage related efficacy and tolerability of cannabidiol in children with treatment-resistant epileptic encephalopathy: preliminary results of the CARE-E study RJ Huntsman, R Tang-Wai, J Alcorn, S Vuong, B Acton, S Corley, ... Frontiers in neurology 10, 716, 2019 | 62 | 2019 |
| Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders DD Mousseau Metabolic brain disease 8, 1-44, 1993 | 61 | 1993 |
| Modification of Akt1 by methylglyoxal promotes the proliferation of vascular smooth muscle cells T Chang, R Wang, DJH Olson, DD Mousseau, ARS Ross, L Wu The FASEB Journal 25 (5), 1746-1757, 2011 | 58 | 2011 |
| Folate/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyperphosphorylation and memory deficits in aged rats W Wei, YH Liu, CE Zhang, Q Wang, Z Wei, DD Mousseau, JZ Wang, ... Journal of Alzheimer's Disease 27 (3), 639-650, 2011 | 58 | 2011 |
| Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology X Cao, Z Wei, GG Gabriel, XM Li, DD Mousseau BMC neuroscience 8, 1-10, 2007 | 56 | 2007 |
| Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine … D D Mousseau, G B Baker Current Topics in Medicinal Chemistry 12 (20), 2163-2176, 2012 | 49 | 2012 |
| Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats GS Chai, DX Duan, RH Ma, JY Shen, HL Li, ZW Ma, Y Luo, L Wang, ... Neuroscience bulletin 30, 923-935, 2014 | 48 | 2014 |
| Serine 209 resides within a putative p38 (MAPK) consensus motif and regulates monoamine oxidase‐A activity X Cao, L Rui, PR Pennington, J Chlan‐Fourney, Z Jiang, Z Wei, XM Li, ... Journal of neurochemistry 111 (1), 101-110, 2009 | 46 | 2009 |
| Profiles of β-amyloid peptides and key secretases in brain autopsy samples differ with sex and APOE ε4 status: impact for risk and progression of Alzheimer disease JNK Nyarko, MO Quartey, PR Pennington, RM Heistad, D Dea, J Poirier, ... Neuroscience 373, 20-36, 2018 | 41 | 2018 |
| The Aβ (1–38) peptide is a negative regulator of the Aβ (1–42) peptide implicated in Alzheimer disease progression MO Quartey, JNK Nyarko, JM Maley, JR Barnes, MAC Bolanos, ... Scientific Reports 11 (1), 431, 2021 | 39 | 2021 |
Glen BakerProfessor Emeritus, Psychiatry, University of AlbertaVerified email at ualberta.ca
